Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children

ClinicalTrials.gov ID: NCT00106028

Public ClinicalTrials.gov record NCT00106028. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00106028
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Warner Chilcott
Industry
Enrollment
143 participants

Conditions and interventions

Interventions

  • risedronate sodium (Actonel) Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
4 Years to 15 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2004
Primary completion
Mar 31, 2008
Completion
Feb 28, 2010
Last update posted
Apr 21, 2013

2004 – 2010

United States locations

U.S. sites
5
U.S. states
5
U.S. cities
5
Facility City State ZIP Site status
Miami Children's Hospital Miami Florida 33155
University of Nebraska Medical Center, Children's Hospital Omaha Nebraska 68114
Hospital for Special Surgery New York New York 10021
Wright State University BioMedical Imaging Laboratory and Miami Valley Hospital Dayton Ohio 45409
Oregon Health & Science University Portland Oregon 97239

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00106028, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 21, 2013 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00106028 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →